Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,600 | -20,500 | -27,200 | -19,600 | -44,200 |
| Depreciation Amortization | 36,600 | 23,700 | 64,600 | 51,300 | 37,100 |
| Income taxes - deferred | -10,600 | -5,900 | -32,100 | -27,800 | -11,500 |
| Accounts receivable | -18,900 | -10,500 | -8,800 | -11,800 | -12,300 |
| Accounts payable and accrued liabilities | -8,200 | -3,200 | 9,200 | -4,800 | 8,100 |
| Other Working Capital | -114,000 | -57,400 | 120,800 | 139,000 | 85,900 |
| Other Operating Activity | 53,500 | 27,300 | -107,900 | -98,200 | 4,300 |
| Operating Cash Flow | $-96,200 | $-46,500 | $18,600 | $28,100 | $67,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,000 | -6,300 | -18,000 | -14,600 | -11,600 |
| Net Acquisitions | N/A | N/A | 379,100 | N/A | N/A |
| Purchase Of Investment | -85,500 | -52,100 | -147,800 | -101,000 | -36,600 |
| Sale Of Investment | 45,200 | 17,100 | 61,100 | 36,800 | 25,000 |
| Other Investing Activity | 0 | 0 | 0 | 379,100 | 32,500 |
| Investing Cash Flow | $-53,300 | $-41,300 | $274,400 | $300,300 | $9,300 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -226,400 | -226,400 | -120,000 |
| Common Stock Issued | 3,000 | 300 | 91,800 | 90,000 | 50,100 |
| Other Financing Activity | -5,300 | -5,100 | -16,000 | -13,100 | -5,100 |
| Financing Cash Flow | $-2,300 | $-4,800 | $-150,600 | $-149,500 | $-75,000 |
| Exchange Rate Effect | -800 | -600 | -600 | -700 | -300 |
| Beginning Cash Position | 258,800 | 258,800 | 117,000 | 117,000 | 117,000 |
| End Cash Position | 106,200 | 165,600 | 258,800 | 295,200 | 118,400 |
| Net Cash Flow | $-152,600 | $-93,200 | $141,800 | $178,200 | $1,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -96,200 | -46,500 | 18,600 | 28,100 | 67,400 |
| Capital Expenditure | -13,000 | -6,300 | -18,000 | -14,600 | -11,600 |
| Free Cash Flow | -109,200 | -52,800 | 600 | 13,500 | 55,800 |